Coya Therapeutics, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Coya Therapeutics, Inc. now
Current reporting with the operating signal separated from the noise.
Why Coya Therapeutics, Inc.’s (COYA) Stock Is Up 5.01%
Investors are testing whether Coya Therapeutics, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Coya Therapeutics, Inc. (COYA) Upgraded to Buy: What Does It Mean for the Stock?
Investors are testing whether Coya Therapeutics, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination ...
The story matters when it changes Coya Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Coya Therapeutics, Inc. Announces Closing of $15.25 Million Initial Public Offering
The story matters when it changes Coya Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest COYA filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Coya Therapeutics, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →